Record overview
Status and phase
Status: NOT_YET_RECRUITING
Phase: PHASE1, PHASE2
Sponsor: Chengdu Kanghong Biotech Co., Ltd.
Condition: Advanced Solid Tumors Cancer
NCT07514975
First-In-Human Study of KHN922 for Injection
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal | rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.